Gut microbiota and the pathogenesis of necrotizing enterocolitis in preterm neonates

Future Microbiology

Volumn 11, Issue 2, 2016, Pages 273-292

  Cassir, Nadim ^a   Simeoni, Umberto ^b   Scola, Bernard La ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Bacteriotherapy; Gut dysbiosis; Gut microbiota; Gut brain axis; Necrotizing enterocolitis; Preterm neonates

Indexed keywords

ANTIBIOTIC AGENT; BILE ACID; ENTEROTOXIN; LACTOFERRIN; LIGAND; TOLL LIKE RECEPTOR; ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BILE ACID METABOLISM; BIOTRANSFORMATION; BRAIN DEVELOPMENT; BRAIN METABOLISM; CARBOHYDRATE METABOLISM; DRUG EXPOSURE; DYSBIOSIS; FEEDING; FERMENTATION; GESTATIONAL AGE; HOST PATHOGEN INTERACTION; HUMAN; IMMATURITY; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA; MICROBIAL COMMUNITY; NECROTIZING ENTEROCOLITIS; NONHUMAN; NUTRIENT; OXIDATIVE STRESS; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; STOMACH PH; ALTERNATIVE MEDICINE; ENTEROCOLITIS, NECROTIZING; GASTROINTESTINAL TRACT; INFANT, PREMATURE, DISEASES; MICROBIOLOGY; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; SYMBIOSIS;

ANTI-BACTERIAL AGENTS; DYSBIOSIS; ENTEROCOLITIS, NECROTIZING; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NATUROPATHY; PROBIOTICS; SYMBIOSIS;

EID: 85012097427     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.136     Document Type: Review

References (162)

1. Neu J. Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr. Rev. 65(6 Pt 1), 282–285 (2007).
2. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 292(5519), 1115–1118 (2001).
3. Stecher B, Hardt WD. The role of microbiota in infectious disease. Trends Microbiol. 16(3), 107–114 (2008).
4. Arboleya S, Binetti A, Salazar N et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol. Ecol. 79(3), 763–772 (2012).
5. Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 308(5), G351–G363 (2015).
6. Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 457(7228), 480–484 (2009).
7. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448(7152), 427–434 (2007).
8. Giongo A, Gano KA, Crabb DB et al. Toward defining the autoimmune microbiome for Type 1 diabetes. ISME J. 5(1), 82–91 (2011).
9. Qin J, Li Y, Cai Z et al. A metagenome-wide association study of gut microbiota in Type 2 diabetes. Nature 490(7418), 55–60 (2012).
10. Antharam VC, Li EC, Ishmael A et al. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 51(9), 2884–2892 (2013).
11. Claud EC, Keegan KP, Brulc JM et al. Bacterial community structure and functional contributions to emergence of health or necrotizing enterocolitis in preterm infants. Microbiome 1(1), 20 (2013).
12. Mai V, Young CM, Ukhanova M et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE 6(6), e20647 (2011).
13. Morrow AL, Lagomarcino AJ, Schibler KR et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome 1(1), 13 (2013).
14. Neu J, Walker WA. Necrotizing enterocolitis. N. Engl. J. Med. 364(3), 255–264 (2011).
15. Holman RC, Stoll BJ, Clarke MJ, Glass RI. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am. J. Public Health. 87(12), 2026–2031 (1997).
16. Fitzgibbons SC, Ching Y, Yu D et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J. Pediatr. Surg. 44(6), 1072–1075; discussion 1075–1076 (2009).
17. Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD. Changes in neurodevelopmental outcomes at 18 to 22 months’ corrected age among infants of less than 25 weeks’ gestational age born in 1993–1999. Pediatrics 115(6), 1645–1651 (2005).
18. Salhab WA, Perlman JM, Silver L, Sue Broyles R. Necrotizing enterocolitis and neurodevelopmental outcome in extremely low birth weight infants <1000 g. J. Perinatol. 24(9), 534–540 (2004).
19. Bedrick AD. Necrotizing enterocolitis: neurodevelopmental ‘risky business.’ J. Perinatol. 24(9), 531–533 (2004).
20. Sántulli TV, Schullinger JN, Heird WC et al. Acute necrotizing enterocolitis in infancy: a review of 64 cases. Pediatrics 55(3), 376–387 (1975).
21. Jacquot A, Neveu D, Aujoulat F et al. Dynamics and clinical evolution of bacterial gut microflora in extremely premature patients. J. Pediatr. 158(3), 390–396 (2011).
22. Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285), 59–65 (2010).
23. Groer MW, Luciano AA, Dishaw LJ, Ashmeade TL, Miller E, Gilbert JA. Development of the preterm infant gut microbiome: a research priority. Microbiome 2, 38 (2014).
24. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9(10), 577–589 (2012).
25. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr. Opin. Biotechnol. 24(2), 160–168 (2013).
26. Mills CD, Ley K. M1 and M2 macrophages: the chicken and the egg of immunity. J. Innate Immun. 6(6), 716–726 (2014).
27. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10(11), 735–742 (2012).
28. Favier CF, Vaughan EE, De Vos WM, Akkermans ADL. Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 68(1), 219–226 (2002).
29. Brown CT, Sharon I, Thomas BC, Castelle CJ, Morowitz MJ, Banfield JF. Genome resolved analysis of a premature infant gut microbial community reveals a Varibaculum cambriense genome and a shift towards fermentation-based metabolism during the third week of life. Microbiome 1(1), 30 (2013).
30. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 5(7), e177 (2007).
31. Koenig JE, Spor A, Scalfone N et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4578–4585 (2011).
32. De Filippo C, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. USA 107(33), 14691–14696 (2010).
33. Lagier J-C, Million M, Hugon P, Armougom F, Raoult D. Human gut microbiota: repertoire and variations. Front. Cell. Infect. Microbiol. 2, 136 (2012).
34. Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat. Rev. Microbiol. 10(5), 323–335 (2012).
35. Pacheco AR, Curtis MM, Ritchie JM et al. Fucose sensing regulates bacterial intestinal colonization. Nature 492(7427), 113–117 (2012).
36. Johansson MEV, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat. Rev. Gastroenterol. Hepatol. 10(6), 352–361 (2013).
37. Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 298(6), G807–G819 (2010).
38. Ashida H, Ogawa M, Kim M, Mimuro H, Sasakawa C. Bacteria and host interactions in the gut epithelial barrier. Nat. Chem. Biol. 8(1), 36–45 (2012).
39. Sharma R, Young C, Neu J. Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J. Biomed. Biotechnol. 2010, 305879 (2010).
40. Peng L, Li Z-R, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 139(9), 1619–1625 (2009).
41. Emami CN, Petrosyan M, Giuliani S et al. Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis. Surg. Infect. 10(5), 407–417 (2009).
42. Huang X-Z, Zhu L-B, Li Z-R, Lin J. Bacterial colonization and intestinal mucosal barrier development. World J. Clin. Pediatr. 2(4), 46–53 (2013).
43. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 136(1), 65–80 (2009).
44. Wick MJ, Madara JL, Fields BN, Normark SJ. Molecular cross talk between epithelial cells and pathogenic microorganisms. Cell 67(4), 651–659 (1991).
45. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 9(5), 356–368 (2011).
46. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host–microbial interface. Proc. Natl Acad. Sci. USA 105(52), 20858–20863 (2008).
47. + regulatory T cells: more of the same or a division of labor? Immunity 30(5), 626–635 (2009).
48. Jakaitis BM, Denning PW. Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses. Pathophysiology ISP 21(1), 47–54 (2014).
49. Jones RM, Luo L, Ardita CS et al. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J. 32(23), 3017–3028 (2013).
50. Mukherjee S, Vaishnava S, Hooper LV. Multi-layered regulation of intestinal antimicrobial defense. Cell. Mol. Life Sci. 65(19), 3019–3027 (2008).
51. Canny GO, McCormick BA. Bacteria in the intestine, helpful residents or enemies from within? Infect. Immun. 76(8), 3360–3373 (2008).
52. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4(6), 478–485 (2004).
53. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8(3), 171–184 (2010).
54. Krajmalnik-Brown R, Ilhan Z-E, Kang D-W, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr. Clin. Pract. 27(2), 201–214 (2012).
55. Wong JMW, de Souza R, Kendall CWC, Emam A, Jenkins DJA. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40(3), 235–243 (2006).
56. Nava GM, Carbonero F, Croix JA, Greenberg E, Gaskins HR. Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon. ISME J. 6(1), 57–70 (2012).
57. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer R-J. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27(2), 104–119 (2008).
58. Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr–Fgf15 axis in mice. Cell Rep. 7(1), 12–18 (2014).
59. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain–gut–enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 6(5), 306–314 (2009).
60. Sudo N, Chida Y, Aiba Y et al. Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice. J. Physiol. 558(Pt 1), 263–275 (2004).
61. Shah TA, Meinzen-Derr J, Gratton T et al. Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation. J. Perinatol. 32(7), 552–558 (2012).
62. Patel RM, Denning PW. Intestinal microbiota and its relationship with necrotizing enterocolitis. Pediatr. Res. 78(3), 232–238 (2015).
63. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 368(9543), 1271–1283 (2006).
64. Wang Y, Hoenig JD, Malin KJ et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 3(8), 944–954 (2009).
65. Mshvildadze M, Neu J, Shuster J, Theriaque D, Li N, Mai V. Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J. Pediatr. 156(1), 20–25 (2010).
66. Normann E, Fahlén A, Engstrand L, Lilja HE. Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta Paediatr. Oslo Nor. 1992 102(2), 129–136 (2013).
67. Millar MR, Linton CJ, Cade A, Glancy D, Hall M, Jalal H. Application of 16S rRNA gene PCR to study bowel flora of preterm infants with and without necrotizing enterocolitis. J. Clin. Microbiol. 34(10), 2506–2510 (1996).
68. Stewart C, Marrs E, Magorrian S et al. The preterm gut microbiota: changes associated with necrotising enterocolitis and infection. Acta Paediatr. Oslo Nor. 1992 101(11), 1121–1127 (2012).
69. Sim K, Shaw AG, Randell P et al. Dysbiosis anticipating necrotizing enterocolitis in very premature infants. Clin. Infect. Dis. 60(3), 389–397 (2014).
70. McMurtry VE, Gupta RW, Tran L et al. Bacterial diversity and Clostridia abundance decrease with increasing severity of necrotizing enterocolitis. Microbiome 3, 11 (2015).
71. Raveh-Sadka T, Thomas BC, Singh A et al. Gut bacteria are rarely shared by co-hospitalized premature infants, regardless of necrotizing enterocolitis development. eLife doi:10.7554/eLife.05477 (2015) (Epub).
72. Zhou Y, Shan G, Sodergren E, Weinstock G, Walker WA, Gregory KE. Longitudinal analysis of the premature infant intestinal microbiome prior to necrotizing enterocolitis: a case–control study. PLoS ONE 10(3), e0118632 (2015).
73. Cassir N, Benamar S, Bou Khalil J et al. Clostridium butyricum strains and dysbiosis linked to necrotizing enterocolitis in preterm neonates. Clin. Infect. Dis. 61(7), 1107–1115 (2015).
74. Li M, Wang M, Donovan SM. Early development of the gut microbiome and immune-mediated childhood disorders. Semin. Reprod. Med. 32(1), 74–86 (2014).
75. DiGiulio DB, Romero R, Amogan HP et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS ONE 3(8), e3056 (2008).
76. Bearfield C, Davenport ES, Sivapathasundaram V, Allaker RP. Possible association between amniotic fluid microorganism infection and microflora in the mouth. BJOG Int. J. Obstet. Gynaecol. 109(5), 527–533 (2002).
77. Sakata H, Yoshioka H, Fujita K. Development of the intestinal flora in very low birth weight infants compared with normal full-term newborns. Eur. J. Pediatr. 144(2), 186–190 (1985).
78. Adlerberth I, Wold AE. Establishment of the gut microbiota in western infants. Acta Paediatr. Oslo Nor. 1992. 98(2), 229–238 (2009).
79. La Rosa PS, Warner BB, Zhou Y et al. Patterned progression of bacterial populations in the premature infant gut. Proc. Natl Acad. Sci. USA 111(34), 12522–12527 (2014).
80. Sharma R, Hudak Ml, Tepas JJ et al. Impact of gestational age on the clinical presentation and surgical outcome of necrotizing enterocolitis. J. Perinatol. 26(6), 342–347 (2006).
81. Neu J, Rushing J. Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin. Perinatol. 38(2), 321–331 (2011).
82. Dominguez-Bello MG, Costello EK, Contreras M et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107(26), 11971–11975 (2010).
83. Biasucci G, Benenati B, Morelli L, Bessi E, Boehm G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J. Nutr. 138(9), 1796S–1800S (2008).
84. Penders J, Thijs C, Vink C et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118(2), 511–521 (2006).
85. Brooks B, Firek BA, Miller CS et al. Microbes in the neonatal intensive care unit resemble those found in the gut of premature infants. Microbiome 2(1), 1 (2014).
86. Ferraris L, Butel M-J, Aires J. Antimicrobial susceptibility and resistance determinants of Clostridium butyricum isolates from preterm infants. Int. J. Antimicrob. Agents 36(5), 420–423 (2010).
87. Boccia D, Stolfi I, Lana S, Moro Ml. Nosocomial necrotising enterocolitis outbreaks: epidemiology and control measures. Eur. J. Pediatr. 160(6), 385–391 (2001).
88. Schmidt B, Mulder IE, Musk CC et al. Establishment of normal gut microbiota is compromised under excessive hygiene conditions. PLoS ONE 6(12), e28284 (2011).
89. Quigley M, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst. Rev. 4, CD002971 (2014).
90. Marcobal A, Barboza M, Sonnenburg ED et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe 10(5), 507–514 (2011).
91. Le Huërou-Luron I, Blat S, Boudry G. Breast- v. formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutr. Res. Rev. 23(1), 23–36 (2010).
92. Embleton ND, Berrington JE, McGuire W, Stewart CJ, Cummings SP. Lactoferrin: antimicrobial activity and therapeutic potential. Semin. Fetal. Neonatal Med. doi:10.1016/j.siny.2013.02.001 (2013) (Epub ahead of print).
93. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 62(22), 2588–2598 (2005).
94. Cotten CM, Taylor S, Stoll B et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123(1), 58–66 (2009).
95. Tanaka S, Kobayashi T, Songjinda P et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol. Med. Microbiol. 56(1), 80–87 (2009).
96. Greenwood C, Morrow AL, Lagomarcino AJ et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J. Pediatr. 165(1), 23–29 (2014).
97. Schumann A. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol. Genomics 23(2), 235–245 (2005).
98. Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14(7), 685–690 (2013).
99. Sekirov I, Tam NM, Jogova M et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76(10), 4726–4736 (2008).
100. Guillet R, Stoll BJ, Cotten CM et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 117(2), e137–e142 (2006).
101. Terrin G, Passariello A, De Curtis M et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 129(1), e40–e45 (2012).
102. Perrone S, Tataranno Ml, Negro S et al. May oxidative stress biomarkers in cord blood predict the occurrence of necrotizing enterocolitis in preterm infants? J. Matern. Fetal Neonatal Med. 25(Suppl. 1), 128–131 (2012).
103. Benson AK, Kelly SA, Legge R et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc. Natl Acad. Sci. USA 107(44), 18933–18938 (2010).
104. Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc. Natl Acad. Sci. USA 101(19), 7404–7408 (2004).
105. Mirpuri J, Sotnikov I, Myers L et al. Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit. PLoS ONE 7(12), e51955 (2012).
106. Emami CN, Chokshi N, Wang J et al. Role of interleukin-10 in the pathogenesis of necrotizing enterocolitis. Am. J. Surg. 203(4), 428–435 (2012).
107. Lin J, Nafday SM, Chauvin SN et al. Variable effects of short chain fatty acids and lactic acid in inducing intestinal mucosal injury in newborn rats. J. Pediatr. Gastroenterol. Nutr. 35(4), 545–550 (2002).
108. Neu J, Weiss MD. Necrotizing enterocolitis: pathophysiology and prevention. JPEN J. Parenter. Enteral Nutr. 23(Suppl. 5), S13–S17 (1999).
109. Chan KL, Ng SP, Chan KW, Wo YH, Tam PKH. Pathogenesis of neonatal necrotizing enterocolitis: a study of the role of intraluminal pressure, age and bacterial concentration. Pediatr. Surg. Int. 19(8), 573–577 (2003).
110. Nafday SM, Chen W, Peng L, Babyatsky MW, Holzman IR, Lin J. Short-chain fatty acids induce colonic mucosal injury in rats with various postnatal ages. Pediatr. Res. 57(2), 201–204 (2005).
111. Cheu HW, Brown DR, Rowe MI. Breath hydrogen excretion as a screening test for the early diagnosis of necrotizing enterocolitis. Am. J. Dis. Child. 1960. 143(2), 156–159 (1989).
112. Szylit O, Butel MJ, Rimbault A. An experimental model of necrotising enterocolitis. Lancet 350(9070), 33–34 (1997).
113. Halpern MD, Dvorak B. Does abnormal bile acid metabolism contribute to NEC? Semin. Perinatol. 32(2), 114–121 (2008).
114. Halpern MD, Holubec H, Saunders TA et al. Bile acids induce ileal damage during experimental necrotizing enterocolitis. Gastroenterology 130(2), 359–372 (2006).
115. Halpern MD, Weitkamp J-H, Mount Patrick SK et al. Apical sodium-dependent bile acid transporter upregulation is associated with necrotizing enterocolitis. Am. J. Physiol. Gastrointest. Liver Physiol. 299(3), G623–G631 (2010).
116. Sherman MP. New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention. Clin. Perinatol. 37(3), 565–579 (2010).
117. Kansagra K, Stoll B, Rognerud C et al. Total parenteral nutrition adversely affects gut barrier function in neonatal piglets. Am. J. Physiol. Gastrointest. Liver Physiol. 285(6), G1162–G1170 (2003).
118. Anand RJ, Leaphart CL, Mollen KP, Hackam DJ. The role of the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock Augusta Ga. 27(2), 124–133 (2007).
119. Bjornvad CR, Thymann T, Deutz NE et al. Enteral feeding induces diet-dependent mucosal dysfunction, bacterial proliferation, and necrotizing enterocolitis in preterm pigs on parenteral nutrition. Am. J. Physiol. Gastrointest. Liver Physiol. 295(5), G1092–G1103 (2008).
120. Thymann T, MØller HK, Stoll B et al. Carbohydrate maldigestion induces necrotizing enterocolitis in preterm pigs. Am. J. Physiol. Gastrointest. Liver Physiol. 297(6), G1115–G1125 (2009).
121. Han VK, Sayed H, Chance GW, Brabyn DG, Shaheed WA. An outbreak of Clostridium difficile necrotizing enterocolitis: a case for oral vancomycin therapy? Pediatrics 71(6), 935–941 (1983).
122. Howard FM, Flynn DM, Bradley JM, Noone P, Szawatkowski M. Outbreak of necrotising enterocolitis caused by Clostridium butyricum. Lancet 2(8048), 1099–1102 (1977).
123. Cushing AH. Necrotizing enterocolitis with Escherichia coli heat-labile enterotoxin. Pediatrics 71(4), 626–630 (1983).
124. Scheifele DW, Bjornson GL, Dyer RA, Dimmick JE. Delta-like toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis. Infect. Immun. 55(9), 2268–2273 (1987).
125. O’Brien AD, Kapral FA. Increased cyclic adenosine 3’,5’-monophosphate content in guinea pig ileum after exposure to Staphylococcus aureus delta-toxin. Infect. Immun. 13(1), 152–162 (1976).
126. Overturf GD, Sherman MP, Scheifele DW, Wong LC. Neonatal necrotizing enterocolitis associated with delta toxin-producing methicillin-resistant Staphylococcus aureus. Pediatr. Infect. Dis. J. 9(2), 88–91 (1990).
127. Ryan A, Lynch M, Smith SM et al. A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog. 7(6), e1002076 (2011).
128. Leaphart CL, Cavallo J, Gribar SC et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J. Immunol. Baltim. Md 1950. 179(7), 4808–4820 (2007).
129. Lu P, Sodhi CP, Hackam DJ. Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis. Pathophysiology ISP. 21(1), 81–93 (2014).
130. Chany C, Moscovici O, Lebon P, Rousset S. Association of coronavirus infection with neonatal necrotizing enterocolitis. Pediatrics 69(2), 209–214 (1982).
131. Birenbaum E, Handsher R, Kuint J et al. Echovirus type 22 outbreak associated with gastro-intestinal disease in a neonatal intensive care unit. Am. J. Perinatol. 14(8), 469–473 (1997).
132. Rotbart HA, Nelson WL, Glode MP et al. Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak. J. Pediatr. 112(1), 87–93 (1988).
133. Herruzo R, Omeñaca F, García S, Diez J, Sánchez-Fauquier A. Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital. Clin. Microbiol. Infect. 15(3), 280–285 (2009).
134. Stuart RL, Tan K, Mahar JE et al. An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3. Pediatr. Infect. Dis. J. 29(7), 644–647 (2010).
135. Turcios-Ruiz RM, Axelrod P, St John K et al. Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit. J. Pediatr. 153(3), 339–344 (2008).
136. Bagci S, Eis-Hübinger AM, Franz AR et al. Detection of astrovirus in premature infants with necrotizing enterocolitis. Pediatr. Infect. Dis. J. 27(4), 347–350 (2008).
137. Lodha A, de Silva N, Petric M, Moore AM. Human torovirus: a new virus associated with neonatal necrotizing enterocolitis. Acta Paediatr. Oslo Nor. 1992. 94(8), 1085–1088 (2005).
138. Johnson FE, Crnic DM, Simmons MA, Lilly JR. Association of fatal Coxsackie B2 viral infection and necrotizing enterocolitis. Arch. Dis. Child. 52(10), 802–804 (1977).
139. Gerards LJ, Hennekam RC, von Dijk WC, Roord JJ, Fleer A. An outbreak of gastroenteritis due to Escherichia coli 0142 H6 in a neonatal department. J. Hosp. Infect. 5(3), 283–288 (1984).
140. Speer ME, Taber LH, Yow MD, Rudolph AJ, Urteaga J, Waller S. Fulminant neonatal sepsis and necrotizing enterocolitis associated with a ‘nonenteropathogenic’ strain of Escherichia coli. J. Pediatr. 89(1), 91–95 (1976).
141. Powell J, Bureau MA, Paré C, Gaildry Ml, Cabana D, Patriquin H. Necrotizing enterocolitis. Epidemic following an outbreak of Enterobacter cloacae type 3305573 in a neonatal intensive care unit. Am. J. Dis. Child. 1960. 134(12), 1152–1154 (1980).
142. van Acker J, de Smet F, Muyldermans G, Bougatef A, Naessens A, Lauwers S. Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J. Clin. Microbiol. 39(1), 293–297 (2001).
143. Gregersen N, Van Nierop W, Von Gottberg A, Duse A, Davies V, Cooper P. Klebsiella pneumoniae with extended spectrum beta-lactamase activity associated with a necrotizing enterocolitis outbreak. Pediatr. Infect. Dis. J. 18(11), 963–967 (1999).
144. Guner YS, Malhotra A, Ford HR, Stein JE, Kelly LK. Association of Escherichia coli O157:H7 with necrotizing enterocolitis in a full-term infant. Pediatr. Surg. Int. 25(5), 459–463 (2009).
145. Warren S, Schreiber JR, Epstein MF. Necrotizing enterocolitis and hemolysis associated with Clostridium perfringens. Am. J. Dis. Child. 1960. 138(7), 686–688 (1984).
146. Dittmar E, Beyer P, Fischer D et al. Necrotizing enterocolitis of the neonate with Clostridium perfringens: diagnosis, clinical course, and role of alpha toxin. Eur. J. Pediatr. 167(8), 891–895 (2008).
147. Kosloske AM, Ball WS Jr, Umland E, Skipper B. Clostridial necrotizing enterocolitis. J. Pediatr. Surg. 20(2), 155–159 (1985).
148. Alfa MJ, Robson D, Davi M, Bernard K, Van Caeseele P, Harding GKM. An outbreak of necrotizing enterocolitis associated with a novel clostridium species in a neonatal intensive care unit. Clin. Infect. Dis. 35(Suppl. 1), S101–S105 (2002).
149. Sturm R, Staneck JL, Stauffer LR, Neblett WW 3rd. Neonatal necrotizing enterocolitis associated with penicillin-resistant, toxigenic Clostridium butyricum. Pediatrics 66(6), 928–931 (1980).
150. Adler A, Gottesman G, Dolfin T et al. Bacillus species sepsis in the neonatal intensive care unit. J. Infect. 51(5), 390–395 (2005).
151. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 336(8730), 1519–1523 (1990).
152. Sullivan S, Schanler RJ, Kim JH et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J. Pediatr. 156(4), 562–567.e1 (2010).
153. Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst. Rev. 12, CD001241 (2014).
154. Morgan J, Young L, McGuire W. Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst. Rev. 12, CD001970 (2014).
155. Premji SS, Chessell L. Continuous nasogastric milk feeding versus intermittent bolus milk feeding for premature infants less than 1500 grams. Cochrane Database Syst. Rev. (11), CD001819 (2011).
156. Manzoni P, Meyer M, Stolfi I et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum. Dev. 90(Suppl. 1), S60–S65 (2014).
157. Salvini F, Riva E, Salvatici E et al. A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects. J. Nutr. 141(7), 1335–1339 (2011).
158. Srinivasjois R, Rao S, Patole S. Prebiotic supplementation in preterm neonates: updated systematic review and meta-analysis of randomised controlled trials. Clin. Nutr. Edinb. Scotl. 32(6), 958–965 (2013).
159. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 4, CD005496 (2014).
160. Fallon EM, Nehra D, Potemkin AK et al. A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J. Parenter. Enteral Nutr. 36(5), 506–523 (2012).
161. Russell G, Kaplan J, Ferraro M, Michelow IC. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics 126(1), e239–e242 (2010).
162. Wang J, Xiao Y, Lin K, Song F, Ge T, Zhang T. Pediatric severe pseudomembranous enteritis treated with fecal microbiota transplantation in a 13-month-old infant. Biomed. Rep. 3(2), 173–175 (2015).